SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is currently trending with explosive trading and multiple halts after announcing a binding strategic partnership with Crypto.com/us to exclusively launch event-based prediction markets in the United States. The community is highly engaged, driving a strong short squeeze narrative and anticipating significant growth as ROLR positions itself as a pioneering player in the trillion-dollar prediction market space with a major crypto partner.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to robust preliminary revenue guidance for its flagship MS drug Briumvi, which is surpassing expectations for 2025 and 2026 and positioning it for potential blockbuster status. The community is actively discussing Briumvi's best-in-class profile and market share expansion, especially amidst a competitor's recent regulatory setback, while also expressing frustration over the stock's current valuation and perceived manipulation.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending amid multiple analyst upgrades, underscoring its strengthened position in mobile gaming advertising, the promising Vector AI platform, and new payment solutions. The community is actively debating Unity's competitive advantages in its ecosystem against rivals, with many anticipating a significant breakout fueled by these strategic initiatives.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is actively trending following recent analyst downgrades, which many in the community view as an orchestrated move to drive down share price ahead of key future developments. This has sparked a heated debate, with bullish investors aggressively buying the dip, confident in the impending R2 vehicle launch and potential for a significant market rebound.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to widespread discussion around a potential all-cash offer for Warner Bros. Discovery assets, with many viewing this as a strategic move to avoid dilution and signal confidence ahead of upcoming earnings. This development has ignited a fervent debate among traders; bulls foresee a significant short squeeze and rebound from recent lows, while bears express skepticism, highlighting concerns over increased debt and continued technical weakness.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is a hot topic as multiple analysts have recently reiterated or upgraded ratings and raised price targets, emphasizing its AI-powered AXON platform and expanding e-commerce presence. Despite this bullish institutional sentiment, the stock experiences significant intraday volatility, leading to active community discussions about market manipulation and the viability of buying dips or shorting rallies.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing significant market activity and community buzz, fueled by an anticipated presence at the J.P. Morgan Healthcare Conference and a recent positive analyst rating. High short interest remains a key talking point, with many investors speculating about a potential short squeeze and closely watching for strategic updates regarding its Matrix-M platform. While some anticipate a major breakout, others express ongoing skepticism and frustration with management's perceived lack of execution.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is buzzing with activity, driven by compelling clinical data for its Alpha DaRT therapy in pancreatic cancer and high anticipation for Japanese market approval. Community discussions are focused on the company's prominent presence at a major healthcare conference and emerging institutional interest, signaling a potential revaluation for its innovative precision oncology approach.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is trending due to significant advancements in its BTCFi ecosystem and the strategic integration of Bitcoin staking for network consensus. The community is buzzing about its advanced ZK-STARK technology, quantum resistance, and native Account Abstraction, which promise a seamless user experience and superior scalability. With growing Total Value Locked and record staking figures, many see Starknet as a leading Layer 2 poised for substantial long-term growth and broader crypto adoption.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending amidst robust Black Friday/Cyber Monday sales results, demonstrating strong merchant activity even with earlier platform issues. The community is actively discussing the company's aggressive AI integrations with major platforms, which is fueling bullish sentiment around its long-term growth as a leading e-commerce infrastructure provider, while some continue to debate its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PPCB Propanc has completed the administrative SEC filing tied to previously authorized financing arrangements. 
 This filing is part of the standard procedural cycle for Nasdaq-listed biotechnology companies and ensures that all documentation remains current and aligned with reporting requirements. 
 
With this step finalized, the Company continues executing its operational plan for the coming quarters. 
 Key activities include bioanalytical method validation, GMP manufacturing process development, and regulatory documentation to support the planned Phase 1b First-in-Human study. 
 
This administrative update does not alter Propanc’s scientific direction or development priorities. 
 
The strategic focus remains centered on advancing PRP through its defined preclinical milestones and maintaining a clear path toward clinical evaluation. 
 
Propanc will continue to communicate progress on validated scientific and regulatory outcomes as we move into the next stage of development.

Tonda Cajka

StockTwits Web

Propanc Biopharma Inc

 Propanc has completed the administrative SEC filing tied to previously authorized financing arrangements. 
 This filing is part of the standard procedural cycle for Nasdaq-listed biotechnology companies and ensures that all documentation remains current and aligned with reporting requirements. 
 
With this step finalized, the Company continues executing its operational plan for the coming quarters. 
 Key activities include bioanalytical method validation, GMP manufacturing process development, and regulatory documentation to support the planned Phase 1b First-in-Human study. 
 
This administrative update does not alter Propanc’s scientific direction or development priorities. 
 
The strategic focus remains centered on advancing PRP through its defined preclinical milestones and maintaining a clear path toward clinical evaluation. 
 
Propanc will continue to communicate progress on validated scientific and regulatory outcomes as we move into the next stage of development.

This account has been verified as an official PPCB representative.